Log in to save to my catalogue

Atypical meningiomas with an immunohistochemical profile consistent with hypermetabolic or prolifera...

Atypical meningiomas with an immunohistochemical profile consistent with hypermetabolic or prolifera...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10326084

Atypical meningiomas with an immunohistochemical profile consistent with hypermetabolic or proliferative molecular groups show high mitotic index, chromosomal instability, and higher recurrence risk

About this item

Full title

Atypical meningiomas with an immunohistochemical profile consistent with hypermetabolic or proliferative molecular groups show high mitotic index, chromosomal instability, and higher recurrence risk

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Virchows Archiv : an international journal of pathology, 2023-07, Vol.483 (1), p.97-104

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

The use of adjuvant radiotherapy is controversial for atypical meningiomas undergoing gross total resection. It has recently been proposed that meningiomas may be classified into four molecular groups (MG): immunogenic (MG1), benign
NF2
-wildtype (MG2), hypermetabolic (MG3), and proliferative (MG4). The two latter have the worst prognosis, an...

Alternative Titles

Full title

Atypical meningiomas with an immunohistochemical profile consistent with hypermetabolic or proliferative molecular groups show high mitotic index, chromosomal instability, and higher recurrence risk

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10326084

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10326084

Other Identifiers

ISSN

0945-6317

E-ISSN

1432-2307

DOI

10.1007/s00428-023-03537-2

How to access this item